Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-13

Clinical Trial Update: Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in Autonomic [Phase 1]

View source ↗

Summary

A Phase 1 trial update exploring whether reducing splanchnic capacitance contributes to sympathetic hypertension in autonomic disorders. The study includes cond…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Vanderbilt University | Conditions: Multiple System Atrophy, Orthostatic Hypotension | Phase 1 | Status: ACTIVE_NOT_RECRUITING